Clinical trials

  • Inclisiran for Primary hypercholesterolaemia (heterozygous familial and non-familial) | Mixed dyslipidaemia associated with atherosclerotic cardiovascular disease
  • STK-012 for Non-small cell lung cancer
  • Rituximab for Psychosis | Obsessive-compulsive disorder
  • Midazolam hydrochloride for Preoperative anxiety
  • empagliflozin for Metabolic dysfunction-associated steatohepatitis|Non-alcoholic steatohepatitis (NASH)
  • PEMBROLIZUMAB for Cutaneous melanoma | Advanced (stage III/IV) cutaneous melanoma
  • ETX-19477 for Advanced solid malignancies | Ovarian epithelial cancer | Castration-resistant prostate cancer | Breast cancer
  • AZD5335 for Advanced platinum-resistant epithelial ovarian cancer | High-grade serous epithelial ovarian cancer | Primary peritoneal cancer | Fallopian tube cancer
  • LUTETIUM (177LU) OXODOTREOTIDE for Gastroenteropancreatic neuroendocrine tumor (GEP-NET)
  • IG-TREGS for Graft-versus-host disease (GvHD)|Allogeneic haematopoietic stem cell transplantation
  • GSK5784283 for Asthma
  • Gozetotide for Prostate cancer